ARWR vs GOEV
Arrowhead Pharmaceuticals Inc (ARWR) versus GOEV (GOEV) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
GOEV (GOEV) common stock.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
GOEV does not have a complete income-statement cache yet.
ARWR currently screens at market cap $10.59B.
Not investment advice. Open the ARWR and GOEV stock pages for the full models.
Not investment advice.